University of Michigan develops advanced PSA interpretation tool to improve prostate cancer outcomes

A tool to aid with PSA result interpretation has been developed by University of Michigan scientists, according to a release. The goal of this action is to enhance precision medicine and patient outcomes.

The model can inform patient life expectancy, according to the University of Michigan. The researchers claim their model is faster and more accurate than current risk calculators, and ensures that only patients who will benefit from additional screening and treatment will receive it.

When testing the model utilizing over 200,000 PSA scores, it successfully forecasted the patients’ risk of death from prostate cancer and pinpointed the patients that should undergo more treatment. The researchers noted that the data they used for the study was from twenty years ago. However, they are “now working to implement their model in clinical settings.”